The occurrence of cardiovascular disease during 5-year follow-up in patients with idiopathic atrial fibrillation

Europace

Volumn 15, Issue 1, 2013, Pages 18-23

  Weijs, B ^a   De Vos, C B ^a   Tieleman, R G ^b   Peeters, F E C M ^a   Limantoro, I ^a   Kroon, A A ^a   Cheriex, E C ^a   Pisters, R ^a   Crijns, H J G M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

Author keywords

Cardiovascular disease; Follow up; Idiopathic atrial fibrillation

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE WALL; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; MALE; MEDICAL HISTORY; PREDICTION; PRIORITY JOURNAL; SINUS RHYTHM;

ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; RISK FACTORS;

EID: 84871192707     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus203     Document Type: Article

References (21)

1. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. J Am Med Assoc 1985;254:3449-53 (Pubitemid 16148410)
2. Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL et al. Longterm progression and outcomes with aging in patients with lone atrial fibrillation: A 30-year follow-up study. Circulation 2007;115:3050-6 (Pubitemid 46956493)
3. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR Jr, Ilstrup DM et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 1987;317:669-74 (Pubitemid 17138192)
4. Jouven X, Desnos M, Guerot C, Ducimetiere P. Idiopathic atrial fibrillation as a risk factor for mortality. The Paris Prospective Study I. Eur Heart J 1999;20:896-9 (Pubitemid 29253736)
5. Kopecky SL, Gersh BJ, McGoon MD, Chu CP, Ilstrup DM, Chesebro JH et al. Lone atrial fibrillation in elderly persons: A marker for cardiovascular risk. Arch Intern Med 1999;159:1118-22 (Pubitemid 29230865)
6. Osranek M, Bursi F, Bailey KR, Grossardt BR, Brown RD Jr, Kopecky SL et al. Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: Three-decade follow-up. Eur Heart J 2005;26:2556-61 (Pubitemid 41679360)
7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70 (Pubitemid 29135798)
8. Crijns HJ, Van den Berg MP, Van Gelder IC, Van Veldhuisen DJ. Management of atrial fibrillation in the setting of heart failure. Eur Heart J 1997;18(Suppl. C): c45-9 (Pubitemid 27207875)
9. Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet 2009;373:155-66
10. Fu R, Wu S, Wu P, Qiu J. A study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation. Europace 2011;13: 31-6
11. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010;12:1360-420
12. Akutsu Y, Kaneko K, Kodama Y, Li HL, Suyama J, Shinozuka A et al. Significance of cardiac sympathetic nervous system abnormality for predicting vascular events in patients with idiopathic paroxysmal atrial fibrillation. Eur J Nucl Med Mol Imaging 2010;37:742-9
13. de Bono JP, Stoll VM, Joshi A, Rajappan K, Bashir Y, Betts TR. Cavotricuspid isthmus dependent flutter is associated with an increased incidence of occult coronary artery disease. Europace 2010;12:1774-7
14. Katritsis DG, Toumpoulis IK, Giazitzoglou E, Korovesis S, Karabinos I, Paxinos G et al. Latent arterial hypertension in apparently lone atrial fibrillation. J Interv Card Electrophysiol 2005;13:203-7 (Pubitemid 41367257)
15. Weijs B, Smulders MW, Alzand BS. Semi-final masked hypertension. Neth J Med 2010;68:328
16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-52 (Pubitemid 37553153)
17. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: A cohort study. Lancet 2001;358:1682-6 (Pubitemid 33124327)
18. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010;375:895-905
19. Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation 2009;119:2146-52
20. Benjamin EJ, D'Agostino RB, Belanger AJ,Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation 1995;92:835-41
21. Davidson E, Rotenberg Z, Weinberger I, Fuchs J, Agmon J. Diagnosis and characteristics of lone atrial fibrillation. Chest 1989;95:1048-50 (Pubitemid 19136998)